MedPath

STERISCIENCE SPECIALTIES PRIVATE LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

FDA:16

Drug Approvals

Ampicillin Sodium and Sulbactam Sodium

Approval Date
May 1, 2025
FDA

Ampicillin

Approval Date
Feb 1, 2025
FDA

Sodium Bicarbonate

Approval Date
Mar 4, 2024
FDA

Midazolam

Approval Date
Dec 13, 2023
FDA

Midazolam

Approval Date
Dec 13, 2023
FDA

NAFCILLIN SODIUM

Approval Date
Oct 17, 2023
FDA

KETOROLAC TROMETHAMINE

Approval Date
Jul 5, 2023
FDA

piperacillin and tazobactam

Approval Date
Jul 5, 2023
FDA

KETOROLAC TROMETHAMINE

Approval Date
Jul 5, 2023
FDA

ondansetron hydrochloride

Approval Date
Jul 5, 2023
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.